Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Kyle Kathryn W
EVP, Chief Legal Officer·Direct
Exercise · Acquire
Common Stock
Shares+256
Price-
Total Value$0
Shares Owned After4.07K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Kyle Kathryn W
EVP, Chief Legal Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-73
Price$283.88
Total Value$20.7K
Shares Owned After4.00K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Stock withholding to satisfy tax withholding obligations.
Kyle Kathryn W
EVP, Chief Legal Officer·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-256
Price$0.00
Total Value$0
Shares Owned After2.01K
Transaction DateJul 1, 2026
10b5-1
Footnotes ▸
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. | The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. | The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. | This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Post-Transaction Holdings
Kyle Kathryn W
Security
Shares
Change
Common Stock
3.90K
+91 (2.39%)
Restricted Stock Unit
2.01K
-256 (-11.31%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-01
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: LABCORP HOLDINGS INC. (LH)
CIK: 0000920148
--- Reporting Owner ---
Name: Kyle Kathryn W
CIK: 0002103996
Role: Officer (EVP, Chief Legal Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-07-01 | Code: M (Exercise of derivative)
Shares: +256
Shares Owned After: 4,069.4574 | Ownership: D (Direct)
Footnotes:
[F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[Transaction #2]
Security: Common Stock
Date: 2026-07-01 | Code: F (Payment of exercise/tax)
Shares: -73 | Price: $283.88
Total Value: $20,723.24
Shares Owned After: 3,996.4574 | Ownership: D (Direct)
Footnotes:
[F2] Stock withholding to satisfy tax withholding obligations.
[Transaction #3]
Security: Common Stock
Date: 2026-07-02 | Code: S (Open market sale)
Shares: -92 | Price: $286.19
Total Value: $26,329.48
Shares Owned After: 3,904.4574 | Ownership: D (Direct)
Footnotes:
[F3] Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Unit
Date: 2026-07-01 | Code: M (Exercise of derivative)
Shares: -256 | Price: $0.00
Shares Owned After: 2,008 | Ownership: D (Direct)
Footnotes:
[F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F4] The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
[F4] The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
[F5] This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Footnotes (Complete Index) ---
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Signature ---
/s/ /s/ Kathryn W. Kyle (2026-07-06)